60° Pharmaceuticals (60P) continues to fulfill its promise of developing medicines for infectious diseases. Such diseases include COVID-19, babesiosis, fungal diseases, malaria, and dengue fever.* Despite competitive drug development pipelines for these diseases, critical gaps remain.
Cases and 1 Million+ deaths in the U.S. from COVID-19 infections
Annual deaths from malaria globally
Travelers to malaria endemic regions per annum
Annual dengue infections globally